Intellipharmaceutics International Inc.
IPCIF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Market Cap | $2,316 | $3,532 | $3,063 | $3,237 |
| - Cash | $84 | $84 | $772 | $202 |
| + Debt | $2,326 | $2,326 | $1,917 | $2,113 |
| Enterprise Value | $4,559 | $5,774 | $4,208 | $5,148 |
| Revenue | $66 | $66 | $1,402 | $1,402 |
| % Growth | 0% | -95.3% | 0% | – |
| Gross Profit | $66 | -$191 | $971 | $1,368 |
| % Margin | 100% | -290.2% | 69.3% | 97.6% |
| EBITDA | -$2,644 | -$2,644 | -$3,912 | -$1,763 |
| % Margin | -4,023.3% | -4,023.3% | -279.1% | -125.8% |
| Net Income | -$2,892 | -$2,892 | -$5,145 | -$3,391 |
| % Margin | -4,400.6% | -4,400.6% | -367.1% | -241.9% |
| EPS Diluted | -0.087 | -0.098 | -0.22 | -0.16 |
| % Growth | 11.1% | 55.3% | -37.5% | – |
| Operating Cash Flow | -$1,388 | -$1,388 | -$2,461 | $112 |
| Capital Expenditures | $0 | $0 | -$4 | -$4 |
| Free Cash Flow | -$1,388 | -$1,388 | -$2,465 | $108 |